- Markets
- Technology
- Specialty Extrusion
- Foster Pharma
- Capabilities
- Quality
- Support
- Supply Chain Solutions
- Our Company
Introduction to Foster PharmaRecent advances in drug discovery have led to a new class of promising active pharmaceutical ingredients (APIs) that are poorly water soluble (PWS). These PWS drugs cannot be processed using traditional, aqueous methods. Melt extrusion is emerging as the best technology to solve the problem.
Foster Pharma is a business uniquely positioned to meet this unmet need by virtue of its core capabilities. It can help the customer with the full range of challenges, from developing and compounding raw materials through production using melt extrusion and packaging with:
|
Foster Pharma has the capability to source, compound, extrude, and process many combinations of APIs, excipients, and polymer final products. | |
![]() |
||